{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/delirium/background-information/prognosis/","result":{"pageContext":{"chapter":{"id":"ca4b25bd-2486-55a7-92c0-c39322caa272","slug":"prognosis","fullItemName":"Prognosis","depth":2,"htmlHeader":"<!-- begin field 7e4ff409-eb8e-40bb-9957-9725e5c4cf03 --><h2>What is the prognosis?</h2><!-- end field 7e4ff409-eb8e-40bb-9957-9725e5c4cf03 -->","summary":"","htmlStringContent":"<!-- begin item fff952c2-4eac-4234-8cc3-c474b0244ce2 --><!-- begin field 4e392988-ab56-4262-8e24-b41678d09390 --><ul><li><strong>Delirium has a fluctuating course and recovery can be rapid or take weeks to months</strong> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/delirium/references/\">RACGP, 2006</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/delirium/references/\">BMJ Best Practice, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/delirium/references/\">Raju, 2015</a>]<strong>.</strong><ul><li>In one hospital-based study [<a class=\"bibliography-reference internal-reference\" href=\"/topics/delirium/references/\">O'Keeffe, 1997</a>] delirium persisted for 1 week in 60% of people, two weeks in 20%, 4 weeks in 15%, and more than 4 weeks in 5%. Persistent delirium occurs more often in older hospitalized patients, and is associated with adverse outcomes [<a class=\"bibliography-reference internal-reference\" href=\"/topics/delirium/references/\">Australian and New Zealand Society for Geriatric Medicine, 2012</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/delirium/references/\">BMJ Best Practice, 2015</a>].</li><li>Physical function can be impaired for 30 days or more after discharge in people who have developed delirium in hospital [<a class=\"bibliography-reference internal-reference\" href=\"/topics/delirium/references/\">Inouye, 2014</a>].</li><li>‘Subsyndromal’ delirium (symptoms of disorientation, inattention, and memory impairment which do not fulfil the diagnostic criteria for delirium) may persist for up to 12 months [<a class=\"bibliography-reference internal-reference\" href=\"/topics/delirium/references/\">Australian and New Zealand Society for Geriatric Medicine, 2012</a>].</li><li>Cognitive impairment is common in surgical patients who develop delirium and can persist for up to a year [<a class=\"bibliography-reference internal-reference\" href=\"/topics/delirium/references/\">Inouye, 2014</a>].</li></ul></li><li><strong>Factors associated with a poorer prognosis include</strong> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/delirium/references/\">Raju, 2015</a>]:<ul><li><strong>Pre-existing dementia or cognitive impairment.</strong><ul><li>A secondary analysis of data [<a class=\"bibliography-reference internal-reference\" href=\"/topics/delirium/references/\">Fong, 2009</a>] from a prospective cohort study (n = 408) of patients with Alzheimer's disease (AD) found that cognitive decline was significantly accelerated in those who had an episode of delirium compared to those who did not have delirium [<a class=\"bibliography-reference internal-reference\" href=\"/topics/delirium/references/\">NHS Evidence, 2012</a>]. </li><li>A study looking at prospectively collected data from a nested cohort of hospitalized people with AD (n = 263), found that the rate of cognitive decline doubled over the year following hospitalization in those who had delirium, and that this accelerated decline persisted over the 5 year follow-up period [<a class=\"bibliography-reference internal-reference\" href=\"/topics/delirium/references/\">Gross, 2012</a>].</li></ul></li><li><strong>Hypoxic illness</strong> such as severe pneumonia.</li><li><strong>Visual impairment.</strong></li></ul></li></ul><!-- end field 4e392988-ab56-4262-8e24-b41678d09390 --><!-- end item fff952c2-4eac-4234-8cc3-c474b0244ce2 -->","topic":{"id":"6b89f111-d1d1-510e-8846-71e15c389f06","topicId":"64430de8-33e7-409d-b433-725a712a6f41","topicName":"Delirium","slug":"delirium","lastRevised":"Last revised in April 2020","chapters":[{"id":"0455d257-6ef6-5e50-9dc0-21780666b8e7","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"a71db69b-5a97-544a-a806-ec82704f3907","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"58e84228-4844-5721-859b-91d58faa7eb6","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"999affe9-788e-52a9-83c8-ad933103eeb5","slug":"changes","fullItemName":"Changes"},{"id":"29c67640-566b-5fa4-8966-5b08ca667756","slug":"update","fullItemName":"Update"}]},{"id":"6dddaa0e-c24c-5f4e-8044-6a3229f859df","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"7e8bf385-fd9a-544a-bc9d-375555c17ab0","slug":"goals","fullItemName":"Goals"},{"id":"8f18311c-4fad-5969-8a94-addcca05fb64","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"b45b0c3d-03c0-5300-b0c4-62ccd106e229","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"7b7d4906-4705-52ba-a39f-ecfb7c5d1e98","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"331ceb18-88fc-530e-aa48-bae28dde9901","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"558ba6d3-06ab-5370-b6b7-09548f2c3c8e","slug":"nice-quality-standards","fullItemName":"NICE Quality standards"}]},{"id":"b6e24e45-958a-5052-800a-ef5c6f140719","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"2b925b35-d493-5d01-bb58-9f18c37e1357","slug":"definition","fullItemName":"Definition"},{"id":"27bd26a5-66e1-5d51-a992-7e06e6a3cdfa","slug":"predisposing-factors","fullItemName":"Predisposing factors"},{"id":"c3582ffa-e505-5580-a3fa-f6a04f0938cc","slug":"precipitating-factors","fullItemName":"Precipitating factors"},{"id":"44402d85-ef9c-562b-ad2c-e99c0d8c60a7","slug":"prevalence","fullItemName":"Prevalence"},{"id":"799dcaa5-4683-5bf0-a9d7-dfc860ab7c81","slug":"complications","fullItemName":"Complications"},{"id":"ca4b25bd-2486-55a7-92c0-c39322caa272","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"993580f3-4201-5dd5-8a6d-f64de509d328","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"3f7d0746-b45f-5f52-8e49-7effac5e3547","slug":"clinical-features","fullItemName":"Clinical features"},{"id":"f84af6b7-85fc-56aa-9554-29d1231a7fd1","slug":"assessment","fullItemName":"Assessment"},{"id":"cc3618cd-d41e-5719-939a-78ed0be305e4","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"9d04a09f-9612-570d-aeb7-c0121bda09c4","fullItemName":"Management","slug":"management","subChapters":[{"id":"81f2aa66-ed46-54f0-80b5-4dfca4afb344","slug":"management","fullItemName":"Scenario: Management"},{"id":"58bb812f-7b3c-57be-aab1-8ae228aff1d1","slug":"covid-19","fullItemName":"Scenario: COVID-19"}]},{"id":"769a3265-9e21-5508-b937-bf6aa4a8f378","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"fa09afb1-cc68-5f68-afbe-7486c91a5ed4","slug":"haloperidol","fullItemName":"Haloperidol"},{"id":"4faac93d-8b62-5294-933f-214a1155f283","slug":"lorazepam","fullItemName":"Lorazepam"},{"id":"c02516c6-89cb-5dc3-99db-17f261f5f80e","slug":"levomepromazine","fullItemName":"Levomepromazine"}]},{"id":"cd438911-3d3a-51dd-8455-3e41c260dd60","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"cec2028c-5183-50fb-9bb7-f20aea64a152","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"a5323429-af72-5d8b-a251-0715c1a15bba","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"26c6273a-60c7-5b9a-b49f-9f9fbb623941","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"b70aed75-14ce-57f4-b2b0-474fa4480d56","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"c5faba8c-4118-59d9-af20-8c8d52a89eb2","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"71e02a81-885f-515f-8852-109bc9b5580f","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"51d66a08-1fc6-5593-8764-c9d4e547d827","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"b6e24e45-958a-5052-800a-ef5c6f140719","slug":"background-information","fullItemName":"Background information"},"subChapters":[]}}},"staticQueryHashes":["3666801979"]}